Process View
Any process that activates or increases the frequency, rate or extent of focal adhesion assembly, the establishment and maturation of focal adhesions.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "positive regulation of focal adhesion assembly"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 1.000 | Human | |
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 1.000 | Human | |
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.996 | ||
| S100B | S100 calcium binding protein B | 0.993 | Human | |
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.992 | Human | |
| CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.984 | Human | |
| VEGFA | vascular endothelial growth factor A | 0.983 | ||
| S100A8 | S100 calcium binding protein A8 | 0.980 | Human | |
| S100A9 | S100 calcium binding protein A9 | 0.971 | Human | |
| S100A11 | S100 calcium binding protein A11 | 0.858 | Human | |
| PTK2 | PTK2 protein tyrosine kinase 2 | 0.843 | ||
| ANGPT2 | angiopoietin 2 | 0.771 | ||
| ANXA2 | annexin A2 | 0.735 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.698 | Human | |
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.669 | ||
| S100A1 | S100 calcium binding protein A1 | 0.669 | Human | |
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.625 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.565 | Human | |
| PGF | placental growth factor | 0.546 | Human | |
| S100A6 | S100 calcium binding protein A6 | 0.521 | Human | |
| NCK2 | NCK adaptor protein 2 | 0.483 | ||
| NRP1 | neuropilin 1 | 0.402 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.381 | ||
| FHL2 | four and a half LIM domains 2 | 0.347 | ||
| GHR | growth hormone receptor | 0.264 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.255 | Human | |
| ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | 0.248 | ||
| AREG | amphiregulin | 0.225 | ||
| TEK | TEK tyrosine kinase, endothelial | 0.220 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.207 | ||
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.198 | ||
| LPXN | leupaxin | 0.188 | Human | |
| SMAD2 | SMAD family member 2 | 0.181 | ||
| S100A4 | S100 calcium binding protein A4 | 0.177 | Human | |
| FXYD5 | FXYD domain containing ion transport regulator 5 | 0.173 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.163 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.157 | ||
| LIMS1 | LIM and senescent cell antigen-like domains 1 | 0.134 | ||
| LAT | linker for activation of T cells | 0.125 | ||
| ILK | integrin-linked kinase | 0.110 | ||
| ANGPT1 | angiopoietin 1 | 0.109 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.105 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.104 | ||
| DPYSL4 | dihydropyrimidinase-like 4 | 0.102 | ||
| PLP2 | proteolipid protein 2 (colonic epithelium-enriched) | 0.097 | ||
| EMP3 | epithelial membrane protein 3 | 0.096 | ||
| PXN | paxillin | 0.083 | Human | |
| FYN | FYN oncogene related to SRC, FGR, YES | 0.080 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.076 | ||
| CAPG | capping protein (actin filament), gelsolin-like | 0.072 | ||
| EGFR | epidermal growth factor receptor | 0.069 | ||
| LGALS1 | lectin, galactoside-binding, soluble, 1 | 0.062 | ||
| SH3BGRL3 | SH3 domain binding glutamic acid-rich protein like 3 | 0.061 | ||
| RHOA | ras homolog gene family, member A | 0.054 | ||
| PTPN23 | protein tyrosine phosphatase, non-receptor type 23 | 0.041 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.040 | ||
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.039 | ||
| TSG101 | tumor susceptibility gene 101 | 0.039 | ||
| KITLG | KIT ligand | 0.038 | ||
| AGER | advanced glycosylation end product-specific receptor | 0.036 | ||
| CD34 | CD34 molecule | 0.035 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.035 | ||
| TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | 0.035 | Human | |
| CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.034 | ||
| DPPA4 | developmental pluripotency associated 4 | 0.033 | ||
| PDGFC | platelet derived growth factor C | 0.031 | ||
| PHC2 | polyhomeotic homolog 2 (Drosophila) | 0.030 | ||
| TRIP6 | thyroid hormone receptor interactor 6 | 0.030 | ||
| HOXA1 | homeobox A1 | 0.029 | ||
| TMSB10 | thymosin beta 10 | 0.028 | ||
| ITGA7 | integrin, alpha 7 | 0.027 | ||
| TIMP1 | TIMP metallopeptidase inhibitor 1 | 0.026 | ||
| AXL | AXL receptor tyrosine kinase | 0.026 | ||
| SH3GL3 | SH3-domain GRB2-like 3 | 0.026 | ||
| ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.025 | ||
| RRAS | related RAS viral (r-ras) oncogene homolog | 0.025 | ||
| LGALS3 | lectin, galactoside-binding, soluble, 3 | 0.025 | ||
| CREBBP | CREB binding protein | 0.023 | ||
| GIT2 | G protein-coupled receptor kinase interacting ArfGAP 2 | 0.022 | ||
| FEM1B | fem-1 homolog b (C. elegans) | 0.022 | ||
| PARVA | parvin, alpha | 0.020 | ||
| ITGA3 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | 0.018 | ||
| FKBP4 | FK506 binding protein 4, 59kDa | 0.018 | ||
| STC1 | stanniocalcin 1 | 0.018 | ||
| LDLR | low density lipoprotein receptor | 0.017 | ||
| NCF2 | neutrophil cytosolic factor 2 | 0.017 | ||
| FLT4 | fms-related tyrosine kinase 4 | 0.017 | Human | |
| EMCN | endomucin | 0.017 | ||
| RHOG | ras homolog gene family, member G (rho G) | 0.017 | Human | |
| ZYX | zyxin | 0.017 | ||
| BGN | biglycan | 0.017 | ||
| S100A10 | S100 calcium binding protein A10 | 0.017 | ||
| CDC42EP3 | CDC42 effector protein (Rho GTPase binding) 3 | 0.017 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.016 | ||
| PHF21A | PHD finger protein 21A | 0.016 | ||
| S100A12 | S100 calcium binding protein A12 | 0.016 | Human | |
| COL5A1 | collagen, type V, alpha 1 | 0.016 | ||
| BBS10 | Bardet-Biedl syndrome 10 | 0.016 | ||
| TSPO | translocator protein (18kDa) | 0.015 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.014 | ||
| RAMP2 | receptor (G protein-coupled) activity modifying protein 2 | 0.014 | ||
| S100P | S100 calcium binding protein P | 0.014 | Human | |
| VWF | von Willebrand factor | 0.014 | ||
| CDC42EP1 | CDC42 effector protein (Rho GTPase binding) 1 | 0.013 | ||
| CSTA | cystatin A (stefin A) | 0.013 | ||
| GJA4 | gap junction protein, alpha 4, 37kDa | 0.013 | ||
| ANXA5 | annexin A5 | 0.013 | ||
| PSG5 | pregnancy specific beta-1-glycoprotein 5 | 0.012 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.012 | ||
| LMNA | lamin A/C | 0.012 | ||
| COTL1 | coactosin-like 1 (Dictyostelium) | 0.012 | ||
| MMRN2 | multimerin 2 | 0.011 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.011 | ||
| ACVRL1 | activin A receptor type II-like 1 | 0.011 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.011 | ||
| PSTPIP1 | proline-serine-threonine phosphatase interacting protein 1 | 0.011 | ||
| AHNAK | AHNAK nucleoprotein | 0.010 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.010 | ||
| LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.010 | ||
| VAT1 | vesicle amine transport protein 1 homolog (T. californica) | 0.010 | ||
| RHOC | ras homolog gene family, member C | 0.010 |